Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers.
about
The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell PhenotypeEnhancing the Tumor Selectivity of a Picornavirus Virotherapy Promotes Tumor Regression and the Accumulation of Infiltrating CD8+ T Cells.Expression of N-Acetylglucosaminyltransferase III Suppresses α2,3-Sialylation, and Its Distinctive Functions in Cell Migration Are Attributed to α2,6-Sialylation Levels.GP73 N-glycosylation at Asn144 reduces hepatocellular carcinoma cell motility and invasiveness.ST6Gal-I modulates docetaxel sensitivity in human hepatocarcinoma cells via the p38 MAPK/caspase pathway.Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasis.A Key Regulator of Cell Adhesion: Identification and Characterization of Important N-Glycosylation Sites on Integrin α5 for Cell Migration.The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential.The blood-borne sialyltransferase ST6Gal-1 is a negative systemic regulator of granulopoiesis.Sialylation of N-glycans: mechanism, cellular compartmentalization and function.IL-13 improves beta-cell survival and protects against IL-1beta-induced beta-cell death.Inhibition of fucosylation by 2-fluorofucose suppresses human liver cancer HepG2 cell proliferation and migration as well as tumor formation.α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway.The Inhibitory Role of α2,6-Sialylation in Adipogenesis.Drug resistance related to aberrant glycosylation in colorectal cancer.ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage.ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling.Extrinsic sialylation is dynamically regulated by systemic triggers in vivo.Plasma N-glycans in colorectal cancer risk.Triple-negative and HER2-overexpressing breast cancer cell sialylation impacts tumor microenvironment T-lymphocyte subset recruitment: a possible mechanism of tumor escape.Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities.
P2860
Q30276749-608E7EC4-FFCF-4C3E-BD3B-4AB4AE984A2EQ36665114-6450FD5A-2665-4D1F-875B-0AE2ECC675B4Q36674650-17E91B87-A289-47D5-9B1D-169FB4142DECQ37269066-1F0E1813-21EA-4E4C-BB99-D5B00F8ADA01Q37588392-86EA624F-D54D-46D5-B7A9-5E78DA14716CQ37702592-F7F9F23E-4726-4A02-8895-DEACBDD825C9Q38717605-5E88C553-9B98-4C01-82D6-6DB32DC71AADQ38718209-F8FCF765-D8EA-4AA8-85AE-A19CA24415D8Q38760708-48D82018-BFFB-49CC-BD50-6DBD2FC764ECQ39038778-C9AE7BA4-1940-448E-8474-BD929DFDA145Q39973592-73354DC0-540F-4C31-9C43-5171C74FFC45Q41047586-798E9A33-7AF0-44EA-9B81-E3C572C58B23Q41098517-33EEF093-71B1-4331-A116-5434978D20E8Q42804212-BB2A3F53-CF8B-4939-A0A2-C4B96A153FA3Q49185043-4D3DF90D-17E2-4184-851B-9C665D7FBC4EQ49388105-657F9FB8-EEE7-477C-B38B-ECB96B7469D1Q49886934-4B87A4D4-ED49-4401-8440-BE7C97253734Q50422095-237A47BE-1B48-46FB-9834-23E4C4F884D8Q50885139-15ACAFAD-2CDF-45F1-A916-F5106F2A1185Q55250879-6A767623-7701-45AE-A92F-1811DC9DD9F3Q55374172-F3B9131C-6E44-44A0-9BD0-B99089EF0E32Q55515607-81692D91-2CB7-40D2-92FA-66614055D137
P2860
Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers.
@en
type
label
Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers.
@en
prefLabel
Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers.
@en
P2860
P1433
P1476
Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers
@en
P2093
P2860
P304
P356
10.3390/MOLECULES20057509
P407
P577
2015-04-24T00:00:00Z